K. Yamac Et Al. , "Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation," ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, pp.827-831, 2000
Yamac, K. Et Al. 2000. Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9 , 827-831.
Yamac, K., Kaptan, K., Beyan, C., Teksin, Z. Ş., Agabeyoglu, I., & Gokgoz, L., (2000). Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, 827-831.
Yamac, K Et Al. "Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation," ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, 827-831, 2000
Yamac, K Et Al. "Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation." ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, pp.827-831, 2000
Yamac, K. Et Al. (2000) . "Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation." ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, pp.827-831.
@article{article, author={K Yamac Et Al. }, title={Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation}, journal={ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH}, year=2000, pages={827-831} }